BIVATUZUMAB MERTANSINE
UNII 074GT4PR9D

Substance Identification & Data

This profile provides standardized clinical and technical data for Bivatuzumab Mertansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 074GT4PR9D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 936332-86-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
074GT4PR9D
CAS Registry Number
936332-86-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BIVATUZUMAB MERTANSINE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C216392
National Cancer Institute reference terminology for clinical and research data.
INN ID
7965
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bivatuzumab Mertansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BIVATUZUMAB MERTANSINE

Common Names & Synonyms

BIWA-4 MERTANSINE

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD44V6 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL BIWA4 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL BIWA4 .KAPPA.-CHAIN, DIMER, MERTANSINE CONJUGATE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus